Kalvista Pharmaceuticals Inc (KALV) — Working Capital to Net Assets Ratio
Kalvista Pharmaceuticals Inc (KALV) has a Working Capital to Net Assets ratio of 1648.1% as of October 2025. Working capital of $280.16 Million (current assets of $325.23 Million minus current liabilities of $45.07 Million) is measured against net assets of $17.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Kalvista Pharmaceuticals Inc balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kalvista Pharmaceuticals Inc Working Capital to Net Assets (2013–2025)
This chart shows how Kalvista Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2013 to 2025. As of October 2025, the ratio stands at 1648.1%, reflecting working capital of $280.16 Million against net assets of $17.00 Million USD. Check Kalvista Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Kalvista Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kalvista Pharmaceuticals Inc from 2013 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Kalvista Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 206.0% | $196.52 Million | $95.39 Million | $241.69 Million | $45.17 Million | ▲ +107.8 pp |
| 2024 | 98.2% | $202.88 Million | $206.58 Million | $225.69 Million | $22.81 Million | ▲ +0.5 pp |
| 2023 | 97.7% | $157.29 Million | $161.03 Million | $172.33 Million | $15.03 Million | ▼ -0.7 pp |
| 2022 | 98.4% | $182.07 Million | $185.09 Million | $193.65 Million | $11.58 Million | ▼ -0.6 pp |
| 2021 | 98.9% | $254.49 Million | $257.19 Million | $264.26 Million | $9.77 Million | ▲ +2.3 pp |
| 2020 | 96.7% | $80.98 Million | $83.75 Million | $88.70 Million | $7.72 Million | ▼ -4.1 pp |
| 2019 | 100.8% | $97.49 Million | $96.74 Million | $115.55 Million | $18.05 Million | ▼ -31.9 pp |
| 2018 | 132.7% | $36.16 Million | $27.25 Million | $59.38 Million | $23.22 Million | ▲ +33.0 pp |
| 2017 | 99.7% | $31.23 Million | $31.33 Million | $34.25 Million | $3.02 Million | ▲ +0.0 pp |
| 2016 | 99.7% | $21.42 Million | $21.50 Million | $24.67 Million | $3.25 Million | ▼ -6.2 pp |
| 2016 | 105.9% | $45.61 Million | $43.07 Million | $49.47 Million | $3.85 Million | ▲ +3.1 pp |
| 2015 | 102.8% | $50.67 Million | $49.31 Million | $54.95 Million | $4.27 Million | ▲ +97.1 pp |
| 2015 | 5.7% | $-2.51 Million | $-44.18 Million | $4.59 Million | $7.09 Million | ▼ -48.5 pp |
| 2014 | 54.2% | $-2.51 Million | $-4.62 Million | $4.59 Million | $7.09 Million | ▲ +71.9 pp |
| 2014 | -17.7% | $5.96 Million | $-33.71 Million | $9.91 Million | $3.95 Million | ▲ +0.9 pp |
| 2013 | -18.6% | $5.26 Million | $-28.29 Million | $8.32 Million | $3.07 Million | — |